HIGH INCIDENCE OF CONGENITAL HYPOTHYROIDISM IN ONE REGION OF THE REPUBLIC OF MACEDONIA
Anastasovska V, Koviloska R, Kocova M,
*Corresponding Author: Professor Dr. Mirjana Kocova, University Clinic of Pediatrics, Vodnjanska 17, 1000 Skopje, Republic of Macedonia. Tel.: +389(0)2-3123-224. Fax: +389(0)2-3111-713. E-mail: mirjanakocova@ yahoo.com
page: 31

RESULTS

During the period of almost 10 years, out of 10,446 live birth neonates, 9757 newborns (5603 males, 4154 females) have been screened. Ethnic distribution of the screened newborns in Prilep was as follows: 73.3% Macedonians, 17.2% Romany, 5.6% Albanians and 3.9% other ethnicities. Compared to the state average, the Romany population is overrepresented in this region (17.2% vs. 7.0%). According to the birth weight, neonates were devided in two groups: above 2500 gr (92.9%) and below 2500 gr (7.1%). The coverage of the screened newborns was 93.4% average. The TSH level was not significantly dependent on the gender of the newborn. There was a statistically significant difference between the TSH level and the timing of newborn screening sampling, before and after 48 hours of birth (p <0.05) (Figure 1). There was also a statistically significant difference between the TSH level and newborn birth weight, above or below 2500 gr (p = 0.01) (Figure 2). A statistically significant predictor of the TSH level was only the timing of newborn screening sampling (p <0.05). Spearman’s correlation coefficient between TSH level, newborn birth weight and gestational age showed a significant positive correlation between birth weight and gestational age (r = 0.369, p<0.01). During the analyzed period, 1.92% newborns had TSH levels above 5 mU/L, indicating iodine sufficiency in Prilep. The percentage of recalled neonates with borderline or abnormal initial TSH values was 0.18%. Out of 18 recalled neonates, 10 (55.6%) were categorized as healthy neonates and eight (44.4%) were diagnosed as CH cases. The incidence of the disease was 1:1220 live births. Among neonates with CH, five (62.5%) were male and three (37.5%) were female (male-to-female ratio 1.6:1). The prevalence of CH among male and female neonates was 0.89/1000 (1:1121) and 0.56/1000 (1:1776), respectively. The difference was statistically significant (p <0.05). The distribution of TSH levels showed that seven (87.1%) of the diagnosed CH neonates had initial TSH values above 20 mU/L. One newborn (12.5%) had a borderline initial TSH value, 11.3 mU/L. The thyroid gland was undetectable on ultrasound in four (50.0%) newborns with CH, thyroid hypoplasia of one lobe was confirmed in two (25.0%), and two (25.0%) had a normal thyroid gland. The median age of treatment initiation with levothyroxin was 10.5 days after birth (6-12 days). Infants diagnosed with CH were closely followed during the first 3 years of life. They were followed-up every 2 months during the first year of life, and every 3 months during the second and third year.



Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006